GSK’s Focuses Bioelectronics Quest On Blocking Single-Organ Neural Signals
This article was originally published in The Pink Sheet Daily
Executive Summary
In the final part of its three-prong effort to advance the nascent field of bioelectronics, GSK will award a $1 million prize to researchers who are first able to solve the single-organ nerve interface challenge. Previously, the pharma launched its bioelectronics R&D unit and Action Potential Venture Capital to spur progress in this area.